Patent and Marketing Exclusivities 101 for Drug Developers

Despite an ever-increasing need for newer, safer, more effective, and more affordable therapies to treat a multitude of diseases and conditions, drug development takes too long, costs too much, and is too uncertain to be undertaken without the conferment of exclusionary rights or entry barriers to m...

Descripción completa

Detalles Bibliográficos
Autores principales: Oronsky, Bryan, Caroen, Scott, Brinkhaus, Franck, Reid, Tony, Stirn, Meaghan, Kumar, Raj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2023
Materias:
Biotechnology, Biochemistry & Molecular Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242760/
https://www.ncbi.nlm.nih.gov/pubmed/36635930
http://dx.doi.org/10.2174/1872208317666230111105223

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242760/
https://www.ncbi.nlm.nih.gov/pubmed/36635930
http://dx.doi.org/10.2174/1872208317666230111105223

Ejemplares similares